PharmaDelve Reaches $300M Valuation With AI to Automate Compliance
They just raised a $32M Series A, 6 months after their seed round
Delve
Deployed's enterprise AI reporting on Delve.
PharmaPharmaDegrees Are Becoming Irrelevant as VCs Are Backing AI Dropouts
Some of the most aggressive and promising AI startups are being built not inside college campuses, but in spite of them.
PharmaDelve Raises $3.3M to Automate Compliance for AI Companies
Delve’s founders believe that AI-driven companies shouldn’t be held back by outdated processes.